Immunotherapy for human glioma: innovative approaches and recent results (Q36284489)

13 August 2017

1 reference

title

Immunotherapy for human glioma: innovative approaches and recent results (English)

1 reference

13 August 2017

1 reference

S Farzana Hussain

1

1 reference

13 August 2017

Amy B Heimberger

series ordinal

2

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Expert Review of Anticancer Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

777-790

1 reference

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Inducible expression of H-2 and Ia antigens on brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Ultrastructural and immunohistological evidence for dendritic-like cells within human choroid plexus epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Chemotaxis by a CNS macrophage, the microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Relationship of lymphocyte invasion and survival of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Humoral immune responses within the human central nervous system following systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Human antiglioma monoclonal antibodies from patients with astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Pharmacologic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Tumor antigens in astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Preliminary trial of specific targeting therapy against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Transforming growth factor-beta inhibits interferon-gamma secretion by lymphokine-activated killer cells stimulated with tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: increased level of soluble IL-2R and reduced protein tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Glutamate release promotes growth of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

Surveillance, intervention and cytotoxicity: is there a protective role of microglia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.777

21 January 2018

Identifiers

DOI

10.1586/14737140.5.5.777

1 reference

13 August 2017

1 reference